Category Archives: Stem Cell Research

Free virtual conference for World Cord Blood Day 2022 (November 15th) to feature renowned transplant doctors and researchers presenting ground-breaking work in cellular therapy using cord blood to treat cancer, HIV, cerebral palsy and autism. In addition, bestselling author, Delia Ephron, to present her memoir about fighting leukemia, "Left on 10th: A Second Chance at Life." TUCSON, Ariz., Oct Continue reading →

DUBLIN--(BUSINESS WIRE)--The "Global Cell Therapy Market, By Use Type, By Therapy Type, By Product, By Technology & By Region- Forecast and Analysis 2022-2028" report has been added to ResearchAndMarkets.com's offering. The Global Cell Therapy Market was valued at USD 14.86 Billion in 2021, and it is expected to reach a value of USD 35.95 Billion by 2028, at a CAGR of 13.45% over the forecast period (2022 - 2028). Continue reading →

Biotechnology companies have broken many medical barriers in the past 40 years, harnessing the technological revolution to bring innovative solutions to medical problems. One flourishing field in biotech is regenerative medicine, a market worth $16.9 billion in 2021. Regenerative medicine harnesses the bodys amazing ability to heal itself, using cutting-edge technology to apply this regenerative power to prompt the body to recover from diseases previously uncured Continue reading →

Smart Immune Smart Immune and Greater Paris University Hospitals (AP-HP) begin groundbreaking Phase I/II trial with ProTcellTM, a thymus-empowered T-cell therapy platform, in adults with blood cancers First trial to inject T cell progenitor cells derived from cord blood using Smart Immunes ProTcellTM platform PARIS, France, October 13, 2022 Smart Immune SAS, a clinical-stage biotechnology company developing ProTcell, a thymus-empowered T-cell therapy platform to fully and rapidly re-arm the immune system, and the Greater Paris University Hospitals (AP-HP), announced today that SMART102, a human T-lymphoid progenitor cell injection derived from cord blood using Smart Immunes ProTcell platform, has entered clinical testing in a trial sponsored and led by Great Paris University Hospitals (AP-HP). The multicenter Phase I/II trial (NCT04707300) is a proof-of-concept, dose escalation, 10-patient study that will evaluate safety and efficacy of SMART102 to accelerate immune reconstitution after allogeneic hematopoietic stem cell transplantation (HSCT) in adult patients with hematological malignancies. SMART102 is an injection into the patient of allogeneic T-cell progenitors produced by Smart Immunes ProTcell platform designed to travel to the patients thymus and become differentiated into fully functional T-cells Continue reading →

Stanford philanthropist and former Stanford Daily Editor-in-Chief Lorry I. Continue reading →

Cell Separation Cell Separation Market report 2022 gives a brief well-informed report so that the purchaser or readers will get help from it for investment in Cell Separation Industry. The report is properly deliberate and gathered by Market professionals and will shed light on the key information that requires from the consumers like market share, size, top key players, and other important data. The Cell Separation Market is expected to increase significantly over the following seven years, exceeding 2022 in terms of revenue, according to this most recent analysis Continue reading →

Stem cell research takes two primary forms: adult stem cells and embryonic stem cells. Each cell line that is harvested offers the opportunity to develop new treatments that may help to stop a plethora of diseases that affect humanity. Cord blood treatments that involve stem cells have helped to treat more than 6,000 people and 60+ diseases and that is just the beginning of what this medical research may offer Continue reading →

Stem cell research is one of the most innovative research methods being used in modern society. Continue reading →

Visiongain Reports Ltd Visiongain has published a new report entitled Mesenchymal Stem Cells Market 2022-2032. It includes profiles of Mesenchymal Stem Cells Market and Forecasts Market Segment by Type {Product (Cell & Cell Lines, Kits Media & Reagents, Others), Services}, Market segment by Source (Bone Marrow, Adipose Tissue, Cord Blood, fallopian Tube, Fetal Liver, Lung, Peripheral Blood, Other Sources), Market Segment by Indication (Bone & Cartilage Repair, cardiovascular Disease, Cancer, GvHD, Inflammatory & Immunological Diseases, Liver Diseases, Other Diseases), Market Segment by Application (Disease Modelling, Drug Discovery & Development, Stem Cell Banking, Tissue Engineering, Toxicology Studies, Other Applications) plus COVID-19 Impact Analysis and Recovery Pattern Analysis (V-shaped, W-shaped, U-shaped, L-shaped), Profiles of Leading Companies, Region and Country. The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032. Continue reading →

Calgary, Alberta--(Newsfile Corp. - September 27, 2022) - Hemostemix Inc. Continue reading →